Check out In Vivo’s list of “ones to watch” in Biopharma and Medtech. Optimum clients Derk Arts, Castor CEO, Jason Foster, Ori Biotech CEO and Greg Mullen, Theragnostics CEO recognised for “bringing something new to the game”.
Results to Inform Development Plan and Dose Selection for Phase 3 LONDON, Oct. 17, 2019 (GLOBE NEWSWIRE) — Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a biopharmaceutical company focused on respiratory diseases, announces that it has randomized the last patient in its Phase 2b dose-ranging study evaluating the effect of nebulized ensifentrine as […]
20 March 2018 | London, UK
26-27 February, 2018 | Zurich, Switzerland
